Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ampk (Homo sapiens (Human)) | BDBM328256![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-6-(4-(4-meth...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328260![]() (N-(4-(4-cyanophenoxy) cyclohexyl)-6-(4-(4- (methy...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328273![]() (6-(4-(3- acetamidophenoxy) piperidine-1-carbonyl)...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328275![]() (6-(4-(3- acetamidophenoxy) piperidine-1-carbonyl)...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328276![]() (6-(4-(3- acetamidophenoxy) piperidine-1-carbonyl)...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328278![]() (US10377742, Compound 416 | US9663496, Compound 416...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328281![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4-(thioph...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328295![]() (6-(4-(3-(cyclopropane- carboxamido)phenoxy) piper...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328298![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-6-(4-(4- (tr...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328307![]() (6-(4-(4-methoxybenzoyl) piperidine-1-carbonyl)- N...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328309![]() (N-(1-(4-cyano-3- fluorobenzyl)piperidin- 4-yl)-6-(...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328312![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-6-(4-(4- (tr...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328335![]() (N-(6-(4- acetylphenoxy)pyridin- 3-yl)-6-(4-(4- flu...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328336![]() (6-(4-(4- fluorophenylsulfonyl) piperidine-1-carbo...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328339![]() (N-(6-(4- acetylphenoxy)pyridin- 3-yl)-6-(4-(4- flu...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328341![]() (N-(6-(4-cyanophenoxy)- 2-methylpyridin-3-yl)-6- (4...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328356![]() (6-(4-(4- (pentafluorosulfanyl) phenoxy)piperidine...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327866![]() (N2-(1-(4- cyanobenzyl)piperidin-4- yl)-N5-(3- benz...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 750 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327867![]() (N-(4-((4- cyanophenyl)sulfonyl) piperidin-4-yl)-5...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 750 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327880![]() (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(2...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327904![]() ((6-(3-(4- cyanobenzylcarbamoyl) phenyl)pyridin-3y...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327920![]() (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327934![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4-(4- flu...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327937![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4-(4- met...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 750 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327946![]() ((4-(4- fluorobenzyl)piperazin- 1-yl)(6-(4- pheneth...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327949![]() ((4-isopropylpiperazin-1- yl)(6-(4- phenethylpipera...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327958![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4- (cyclo...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327960![]() (N-(1-benzylpiperidin-4- yl)-5-(4- phenylpiperazine...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327961![]() (US10377742, Compound 98 | US9663496, Compound 98 |...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327962![]() (N-(4-(4-cyanobenzyl) cyclohexyl)-6-(4-(4- fluorob...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327969![]() (N2-(1-benzylpiperidin-4- yl)-N5-(biphenyl-3- yl)py...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327992![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4-(4- met...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM327998![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4-(4- cya...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328005![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4-((4- fl...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328027![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4-(4- cya...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328047![]() (N-((cis)-4-(4- methoxyphenoxy) cyclohexyl)-5-(4-(...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328057![]() (5-(4-(4- methoxyphenoxy) piperidine-1-carbonyl)- ...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328058![]() (5-(4-(4-fluorophenoxy) piperidine-1-carbonyl)- N-...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328059![]() (5-(4-(4-cyanophenoxy) piperidine-1-carbonyl)- N-(...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328060![]() (N-((cis)-4-(4-cyano-3- fluorophenoxy) cyclohexyl)...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328071![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(3-(4- cya...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328103![]() (N-(1-(3-methoxybenzyl) piperidin-4-yl)-5-(4-(4- (...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328108![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-6-(4-(4- (cy...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328111![]() (6-(4-(4- (cyclopropylsulfonyl) phenoxy)piperidine...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328117![]() (N-((trans)-3-fluoro-1-(4- (trifluoromethoxy) benz...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328121![]() (N-(6-(4- acetylphenoxy)pyridin- 3-yl)-5-(4-(4- (me...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328135![]() (5-(4-(4-fluorophenoxy) piperidine-1-carbonyl)- N-...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328143![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4-(3,4- d...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328155![]() (N-(1-(3,5- difluorobenzyl)piperidin- 4-yl)-5-(4-(p...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ampk (Homo sapiens (Human)) | BDBM328159![]() (N-(1-(3,5- difluorobenzyl)piperidin- 4-yl)-5-(4-(3...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 493 total ) | Next | Last >> |